Eam Global Investors LLC Cytokinetics Inc Transaction History

Eam Global Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $1.2 Million - $3.72 Million	44,612 New	44,612 $3.72 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $491,204 - $708,214	14,477 Added 15.96%	105,202 $4.13 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $2.02 Million - $3.12 Million	-67,767 Reduced 42.76%	90,725 $3.34 Million
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $1.55 Million - $2.09 Million	45,065 Added 39.73%	158,492 $7.22 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $2.1 Million - $4.05 Million	113,427 New	113,427 $4.05 Million
Q4 2020 Feb 11, 2021	SELL	$15.26 - $28.61 $689,523 - $1.29 Million	-45,185 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$20.58 - $28.96 $633,349 - $891,244	-30,775 Reduced 40.51%	45,185 $978,000
Q2 2020 Aug 13, 2020	BUY	$11.15 - $24.64 $846,954 - $1.87 Million	75,960 New	75,960 $1.79 Million

404

126M

3.24M

2.14M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.35B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.